This paper investigates the dosimetric characteristics of stereotactic body radiotherapy (SBRT) treatment plans of spine patients in the prone position compared to the supine position. A feasibility study for treating spine patients in the prone position using a fiducial-less tracking method is presented. One patient with a multilevel spinal metastasis was simulated for SBRT treatment in both the supine and prone position. CT scans of the patient were acquired, and treatment plans were created using the CyberKnife ® planning platform. The potential advantage of the prone setup as a function of lesion location and number of vertebral bodies involved was studied for targets extending over 1, 2 and 3 consecutive vertebral bodies in the thoracic and lumbar spine. The same process was repeated on an anthropomorphic phantom. A dose of 30 Gy in 5 fractions was prescribed to 95% of the tumor volume and the dose to the cord was limited to 25 Gy. To investigate the feasibility of a fiducial-less tracking method in the prone setup, the patient was positioned prone on the treatment table and the spine motion was monitored as a function of time. Patient movement with the respiratory cycle was reduced by means of a belly-board. Plans in the prone and supine position achieved similar tumor coverage and sparing of the critical structures immediately adjacent to the spine (such as cord and esophagus). However, the prone plans systematically resulted in a lower dose to the normal structures located in the anterior part of the body (such as heart for thoracic cases; stomach, lower gastrointestinal tract and liver for lumbar cases). In addition, prone plans resulted in a lower number of monitor units compared to supine plans. Abbreviations: XST 5 Xsight Spine Tracking; VB 5 Vertebral Body; nCI 5 Conformity Index; PIDL 5 Prescription Isodose Line; HI 5 Homogeneity Index; V35 Gy 5 Volume of Target Receiving a Dose of 35 Gy; D99% 5 Minimum Dose Delivered to 99% of the Target; D max 5 Maximum Dose; D mean 5 Mean Dose; DVH 5 Dose Volume Histogram; MU 5 Monitor Units.
Introduction
Stereotactic body radiation therapy (SBRT) has emerged as an innovative treatment option for patients with primary and metastatic spinal lesions (1) (2) (3) (4) (5) (6) (7) . Clinical experience has demonstrated the efficacy of SBRT for pain control (8) and improvement of neurological symptoms in patients with epidural compression (9) . Preliminary studies have shown that higher doses of radiation resulted in better pain control and superior overall clinical outcomes (10-12), particularly when single doses $16 Gy are used (8). The primary concern when delivering such high dose regimens is to limit the dose to the spinal cord in order to minimize the risk of radiation-induced myelopathy (13). However, minimizing the dose to other organs at risks (such as the gastrointestinal tract and the heart) is also important to improve clinical outcomes and quality of life.
The main advantage of SBRT over conventional external beam radiation therapy is the ability to deliver a highly precise and conformal radiation dose to the tumor in 1 to 5 fractions, with a steep dose gradient at its periphery. This result is achieved by combining multiple highly-focused radiation beams with rigid fixation devices or sophisticated image guidance radiation therapy (IGRT) solutions (14).
The CyberKnife system (Accuray Incorporated, Sunnyvale, CA) is a medical device dedicated to stereotactic radiosurgery treatments. It consists of a compact 6 MV linear accelerator mounted on a robotic arm, which enables to direct the radiation to the target from hundreds of different directions (15) . Stereotactic localization is achieved via image-guidance, thus eliminating the need for invasive fixation devices. The imaging system consists of 2 orthogonal x-ray sources and corresponding flat panel detectors. Target localization during radiation delivery is based on automatic registration of the x-ray images with a library of digitally reconstructed radiographs (DRR) generated from the planning CT. Real time images are acquired at regular time intervals (every 15-150 seconds) throughout the treatment. On each image pair the location of the target is identified and the 6-dimensional deviations from the planned position are calculated. These corrections are used to adjust the robot position, so that the radiation is redirected to the actual target location in near-real time.
Depending on the treatment location, different image registration algorithms are used (15). For extracranial applications, the following options are available: fiducial tracking (16); xsight spine tracking (XST) (17); and synchrony motion tracking, for targets that move with respiration (18). Xsight spine tracking is a fiducial-less registration algorithm developed for the treatment of spine patients. It uses the high contrast information contained in the bones of the vertebral column for calculating the 6-dimensional displacement between x-ray image and DRR image. Spine cases were initially treated using fiducials tracking. However, the development of XST made this invasive procedure unnecessary (19) . While fiducial tracking can be used for the treatment of patients in both the supine and prone position, XST is supported for supine treatments only. In addition, XST does not allow tracking respiration-induced target motion. For these reasons, patients with spinal lesions are typically treated in the supine position. Only one group of investigators reported on the treatment of spine patients in the prone position using XST (20).
Developing treatment plans for patients with spinal lesions is often challenging due to the complex shapes of the target and the close proximity of critical structures. Previous authors have reported on the challenges of treatment planning for multi-level spinal metastases (21). Figure 1 shows a clinical example of spinal metastasis at the level of the T8 vertebral body, treated to a dose of 30 Gy in 5 fractions. In addition to limiting the dose to the spinal cord, it is necessary to protect the esophagus and the heart from excessive radiation.
Geometric constraints inherent to the CyberKnife system prevent delivery of beams from underneath the treatment table. This means that patients in the supine position cannot be treated with posterior beams. In the case of spinal lesions, the 6 MV photon beams have to pass through the anterior portion of the body before reaching the target.
Treating patients in prone position can overcome this potential limitation. We hypothesized that the use of posterior beams in spine patients may result in improved dose distribution, particularly for organs at risks anterior to the spine. Primary goal of this study was to compare the dosimetric characteristics of supine and prone CyberKnife treatment plans for patients with single and multi-level spinal lesions. A secondary goal was to investigate the feasibility of treating spine patients in the prone position using XST.
Materials and Methods

Treatment Planning
For one patient, simulation CT scans were acquired in both supine and prone position. In the supine setup, the patient was positioned on a foam pad with knee support, without immobilization devices. In the prone setup, a carbon fiber belly-board (CIVCO Medical Solutions) was used. The board relieved chest compression via the thorax support and improved patient comfort via the support for the upper legs and the soft padding on the cranial side.
The target and organs at risk (spinal cord, esophagus, heart, stomach, liver, and small bowel) were contoured in the supine data set. For consistency, the same contours were copied onto the prone data set after co-registering the prone and supine CT images to match the vertebral bodies (VB) of interest. The contours for the target and spinal cord were identical to those used in the supine dataset, so differences in target coverage and dose to the spinal cord could not be attributed to different contours. The contours of other critical organs were adjusted to match the prone patient anatomy, thus accounting for the fact that in the prone setup these organs are moved further away from the target.
The same process was repeated for an anthropomorphic thorax phantom. The contours of a real patient were copied onto the phantom dataset after co-registering the patient and phantom CT to match the vertebral bodies of interest.
For the patient study, targets extending over 1, 2 and 3 adjacent vertebral bodies in the thoracic (T7-T9) and in the lumbar spine (L1-L3) were considered. The target volume was 34 cc, 64 cc and 80 cc for the T8, T8T9 and T7T8T9 lesions, respectively. The target volume was 29 cc, 76 cc and 112 cc for the L1, L2L3 and L1L2L3 lesions, respectively. For the phantom study, targets encompassing 1, 2 and 3 adjacent VB in the thoracic region (T4-T6) were considered, with volumes of 12 cc, 22 cc and 37 cc, respectively. In all cases, the target volume consisted of the entire vertebral body/bodies. A total of 18 treatment plans (9 for the prone and 9 for the supine position) were generated using the CyberKnife planning platform (MultiPlan ® version 3.5, CyberKnife model G3). The plans were designed to deliver a dose of 30 Gy to 95% of the target volume, while limiting the dose to the spinal cord to 25 Gy. For a given target, plans in the prone and supine position were optimized using the sequential optimization method (15) with identical planning parameters such as monitor unit (MU) limits, volume of interest (VOI) limits, and optimization steps. The plans were generated by a medical physicist specialized in CyberKnife treatment, and each plan typically required 3-4 iterations.
Plan Evaluation
Supine and prone treatment plans were compared in terms of dosimetric characteristics (target coverage, homogeneity, conformity index, and dose to the critical structures), delivery efficiency (number of beams and monitor units (MU)), and planning efficiency. The following parameters were used to evaluate the plan quality:
Target coverage: percentage of target volume receiving a • dose of 30 Gy;
Conformity index (nCI) describes how well the prescrip-• tion isodose volume (PIV) conforms to the target volume (TV): nCI 5 TV 3 PIV/(TIV) 2 , where TIV is the target volume inside the prescription isodose volume (22); Prescription isodose line (PIDL) is the isodose line that • surrounds the margin of the target and it is chosen in the specification of the dose prescription (30 Gy); Homogeneity index (HI) characterizes the level of dose • homogeneity within the target. It depends on the prescription isodose line chosen to cover the margin of the tumor: HI 5 (maximum dose)/(prescription dose); Extension of the hot spot region within the target: V35 • Gy is the relative volume of target receiving a dose of 35 Gy; D99% is the minimum dose delivered to at least 99% of • the target volume; Maximum dose (D • max ) and mean dose (D mean ) delivered to a given critical organ.
A dose-volume histogram (DVH) analysis was performed. For each group of plans, the mean DVH of target and critical organs obtained in the prone and supine position were calculated and compared.
The statistical significance was calculated using the Student's t-test. The t-test compares two sets of data and returns the probability (p-value) that the two samples have come from the same two underlying populations that have the same mean. A p-value ,0.05 indicates a statistically significant difference between the mean values of the two data sets. 
Patient Setup
The feasibility of using XSight spine tracking in the prone position was investigated. The patient was positioned for treatment in the prone position on the carbon fiber bellyboard. X-ray images were acquired and registered to the reference DRRs to obtain the couch correction parameters. After the couch correction parameters were minimized for patient treatment, images were acquired every 20-30 seconds to monitor patient movement over a time period of approximately 5 minutes. This study was performed for one target in the thoracic spine and one target in the lumbar spine.
Results
For all cases, prone and supine plans achieved comparable target coverage and dose homogeneity. The average target coverage was 95.7% and 95.5% (p-value 0.15), and the average homogeneity index was 1.78 and 1.83 (p-value 0.06), in the supine and prone plans, respectively. The plans in the supine position resulted in better conformity index, higher minimum dose to 99% of the target, and smaller extension of the hot spot within the target. The average conformity index was 1.36 and 1.49 (p-value , 0.001), the average D99% was 26.4 Gy and 25.3 Gy (p-value 0.007), and the average V35 Gy was 71.9% and 77.6% (p-value 0.03) for plans in the supine and prone position, respectively.
Plan characteristics including target coverage, HI, nCI, D99% and V35 Gy are presented in Table I for the patient study and the phantom study. No statistically significant difference was observed in the dose to the cord and esophagus among plans obtained in the supine and prone positions. Table II reports the results for maximum and mean dose delivered to cord and esophagus for the patient study and the phantom study. The average cord D max was 21.7 Gy and 20.4 Gy (p-value 0.09), and the average esophagus D max was 26.4 Gy and 26.9 Gy (p-value 0.6), for the supine and prone plans respectively. For targets in the thoracic spine, the prone position resulted in lower dose to the heart compared to the supine position. Table III shows the maximum and mean dose delivered to the heart for plans in the supine and in the prone position for targets extending over 1, 2 and 3 thoracic VB in the patient study and in the phantom study. The average heart D max was 23.8 Gy and 18.0 Gy (p-value 0.04), the average heart D mean was 6.9 Gy and 3.8 Gy (p-value 0.007), for plans in the supine and prone position, respectively. Figure 2 compares the mean DVH characteristics of the prone and supine plans. While no difference between prone and supine plans is observed in the DHV of cord and esophagus, the heart DVH of the prone plans is always lower than that of the supine plans.
For targets in the lumbar spine, the prone position resulted in lower dose to the bowel, liver and stomach compared to the supine position. Table IV presents the maximum and mean organ dose for targets extending over 1, 2 and 3 lumbar VB for prone and supine plans. The average stomach D max is 15.3 Gy and 8.6 Gy, the average stomach D mean is 1.8 Gy and 2.1 Gy for plans in the supine and prone position, respectively. The average bowel D max is 27.3 Gy and 28.0 Gy, the average bowel D mean is 5.4 Gy and 4.3 Gy for plans in the supine and prone position, respectively. The average liver D max is 14.6 Gy and 10.0 Gy, the average liver D mean is 2.1 Gy and 1.3 Gy for plans in the supine and prone position, respectively. Although the bowel D max is slightly higher in the prone plans, the DVH characteristics show that prone plans are better than supine plans at all other dose levels. Figure 3 shows mean DVH for the lumbar spine lesions planned in the prone and supine position. Data for the target, spinal cord, stomach, bowel and liver are presented. From the DVH characteristics it appears that the dose to stomach, bowel and liver is lower for plans developed in the prone position.
Planning and Delivery Efficiency
Comparable planning complexity was observed for prone and supine plans. For a given target, plans in the supine and prone position required similar planning effort and resulted in similar number of beams.
The prone plans consistently had a lower number of MU, compared to the supine plans. The number of MU was on average 14% lower in prone plans than in supine plans. Lower number of MU translates into lower leakage dose to the patient, and faster treatment time. This is particularly important for older CyberKnife units, such as the G3 model, which has a dose rate of 400 MU/minute. The average number of MU was 72528 for the supine plans, and 63753 for the prone plans. For a 400 MU/min linear accelerator, an increase of 8775 MU corresponds to an increase in treatment time of 22 minutes. This effect is less important for CyberKnife systems with higher dose rate (such as 800 or 1000 MU/MIN).
Patient Setup
Preliminary treatment setup data were acquired with the patient on the treatment couch in the prone position. After Phantom 1 VB 9.5 6.9 2.6 1.6 2 VB 12.9 11.8 4. optimal patient alignment was achieved, patient movements from the initial position were recorded for a time interval of approximately 5 minutes. Patient movement was calculated as the difference in the 6-dimensional couch correction parameters from the initial position. For the thoracic spine, all translational shifts were less than 1 mm and all rotational shifts were less than 1 degree. For the lumbar spine, all rotational shifts were less than 1 degree, and the translational shifts in the left-right directions were less than 1 mm. However, the translational shifts in the superior-inferior and anterior-posterior direction showed an increased trend with time. The patient was not monitored long enough to evaluate if stabilization in a new position would occur over time. The shifts from the original setup position as a function of time are presented in Figures 4 and 5 for the thoracic and lumbar spine case, respectively. It is worth noting that the selected patient was very slim and cooperative. These preliminary results cannot be generalized to a larger patient population.
Discussion
The challenge of optimizing CyberKnife plans for spine lesions prompted us to investigate whether the plan quality could be improved by treating patients in prone position. The prone position enables to shorten the effective path length of the photon beam, therefore reducing the entrance dose and the total number of MU. Goal of this study was to assess the advantages of prone treatment setup in terms of dosimetric characteristics and delivery efficiency. Although a thorough analysis of setup uncertainties was outside the scope of this study, a preliminary evaluation of spine movement from the initial setup position was carried out for a patient with a lesion in the thoracic and lumbar spine.
In all examined cases, plans in the prone position resulted in lower dose to the heart for thoracic spine lesions, and lower dose to the bowel, stomach and liver for lumbar spine lesions.
No clinically significant differences between prone and supine plans were observed in the dose to the cord and the esophagus. The radiation delivery was more efficient in the prone plans, as the total number of MU was on average 14% lower than in the supine plans. No difference was observed in terms of planning efficiency, as developing plans in the prone position took a similar time/number of iterations as developing plans in the supine position.
Furweger et al. reported on the treatment of 17 patients with lesions in the lower lumbar and sacral portion of the spine using (20). The authors demonstrated that the treatment of these patients with XST in the prone position is feasible. However, they observed a larger setup uncertainty associated with respiration-induced spine motion and concluded that a 3 mm uniform margin should be added to the PTV volume to compensate for it. In comparison, the same authors reported that a sub-millimeter tracking accuracy is achieved when treating patients in the supine position (19) . A larger PTV margin results in a larger volume of normal tissues receiving high doses of radiation. The reduction in tracking accuracy due to target motion and the extra volume of normal tissues receiving high doses are drawbacks that must be taken into account when considering the use of this technique.
The dosimetric advantage of treating spine patients in the prone position, on one side, and the disadvantage arising from the reduction in tracking accuracy, on the other side, provide a strong motivation for developing new fiducial-less tracking methods, enabling to compensate for spine motion in the prone position. Further studies will be required to evaluate the potential advantages and limitations of prone treatment setup in a larger patient population.
Conclusions
Treating spine patients in the prone position results in superior sparing of selected critical structures (such as heart, liver, stomach and bowel), and in more efficient dose delivery, compared to the supine position. However, the use of posterior beams does not result in a lower dose to the cord and esophagus, or in a more conformal dose distribution. 
